200,647 Orion Corporation A shares converted into B shares

ORION CORPORATION      STOCK EXCHANGE RELEASE 27 APRIL 2015 at 8.30 a.m. EEST 200,647 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 200,647 A shares have been converted into 200,647 B shares. The conversion has been entered into the Trade Register on 27 April 2015...
New York, (informazione.it - comunicati stampa - salute e benessere)

 

 

ORION CORPORATION      STOCK EXCHANGE RELEASE 27 APRIL 2015 at 8.30 a.m. EEST              

 

200,647 Orion Corporation A shares converted into B shares

 

In accordance with Section 3 of the Articles of Association of Orion Corporation, 200,647 A shares have been converted into 200,647 B shares. The conversion has been entered into the Trade Register on 27 April 2015.

 

The total number of shares in Orion Corporation is 141,257,828 which, after the conversion, consists of 40,212,334 A shares and 101,045,494 B shares.

 

 

 

  

Orion Corporation

 

 

 

Olli Huotari
SVP, Corporate Functions

 

Jari Karlson
CFO

 

 

                                                                       

                                                                       

 

 

 

 

Publisher:

Orion Corporation

Communications

Orionintie 1A, FI-02200 Espoo, Finland

Homepage: www.orion.fi

 

 

Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion developes inhaled Easyhaler® pulmonary drugs.

 

Orion's net sales in 2014 amounted to EUR 1,015 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ Helsinki.


Copyright GlobeNewswire

Regulatory News
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire


[HUG#1915074]
Per maggiori informazioni
Ufficio Stampa
 Thomson Reuters (Leggi tutti i comunicati)
3 Times Square
10036 New York, NY
Allegati
Slide ShowSlide Show